case_images: PMC5694993_01
case_images: Clinical appearance of the right dorsal hand 5 and a half months after beginning apremilast.
case_images: CRIDM2017-2386234.001.jpg
case_images: PMC5694993_01_CRIDM2017-2386234.001.jpg
case_images: fig1
case_images: The patient felt that repigmentation of hands and forearms was progressing slowly as seen in Figures 1 and 2.
case_images: Clinical appearance of the right anterior forearm 5 and a half months after beginning apremilast.
case_images: CRIDM2017-2386234.002.jpg
case_images: PMC5694993_01_CRIDM2017-2386234.002.jpg
case_images: fig2
case_images: The patient felt that repigmentation of hands and forearms was progressing slowly as seen in Figures 1 and 2.
case_images: Clinical appearance of the right dorsal hand 13 months after using apremilast 30 mg twice daily.
case_images: CRIDM2017-2386234.003.jpg
case_images: PMC5694993_01_CRIDM2017-2386234.003.jpg
case_images: fig3
case_images: The patient provided images of 7 months without triamcinolone acetonide and 13 months after beginning apremilast 30 mg twice daily as shown in Figures 3 and 4.
case_images: Clinical appearance of the right anterior forearm 13 months after using apremilast 30 mg twice daily.
case_images: CRIDM2017-2386234.004.jpg
case_images: PMC5694993_01_CRIDM2017-2386234.004.jpg
case_images: fig4
case_images: The patient provided images of 7 months without triamcinolone acetonide and 13 months after beginning apremilast 30 mg twice daily as shown in Figures 3 and 4.